Laserfiche WebLink
DOCUMENT NO. 75600: <br />ATTACHIVIENT NO <br />PURCHASE ORDER NO. <br />PERFORNIING AGENCY: PARIS-LAMAR <br />RECENING AGENCY PROGRAM: IMMUNIZA' <br />TERM: January 0 1, 2004 THRU: December 31, <br />67-2005 <br />lA <br />10001782 <br />HEALTH DEPARTMENT <br />DNISION <br />It is mutually agreed by and between the contracting arties to amend the conditions of <br />Document No. 7560022067 2005 -01 as written belo . All other conditions not hereby <br />amended aze to remain in full force and effect. I <br />SECTION I. SCOPE OF WORK is replaced with the <br />The goal of RECENING AGENCY Program is t prevent,* control, and eliminate <br />vaccine-preventable diseases by providing and ad nistering biologicals, promoting <br />immunizations, conducting vaccine-preventable disea e surveillance, assessing vaccine <br />coverage levels, and applying principles of epidemiology and outbreak control measures <br />within budgetary constraints. <br />PERFORMING AGENCY will provide essential pub~ic health services as specified in <br />PERFORMING AGENCY'S approved 2004 Interlo al Application for Immunization <br />Services, dated June 16, 2003, incorporated herein ~ and made part of this contract <br />Attachment. Any revisions to these documents sha~ be approved by RECEIVING <br />AGENCY Program and transmitted in writing to PERF MING AGENCY. <br />PERFORMING AGENCY shall implement an irr <br />adolescents, and adults, with special emphasis on ac <br />the immunization coverage of children two years of ~ <br />of age). PERFORMING AGENCY shall incorpoi <br />systematic approaches designed to eliminate barriers, <br />establish uniform policies. <br />pERFORMING AGENCY shall report all reportable <br />Part 1 §§97.1 - 97.6 and 97.101 - 97.102. <br />PERFORMING AGENCY shall report all vac< <br />accordance with the National Childhood Vaccine Inj <br />PERFORMING AGENCY shall inform and <br />vaccine-preventable diseases. <br />nization program for children, <br />erating interventions to improve <br />or younger (less than 36 months <br />traditional and non-traditional, <br />pand immunization delivery, and <br />itions as specified in 25 TAC <br />adverse event occurrences in <br />Act of 1986. <br />the public about vaccines and <br />ATTACHVIENT - Page 1 <br />